Trichloroethylene: A current review of metabolism, mode of action, and regulatory considerations

Toxic Substance Mechanisms

Volumn 17, Issue 2, 1998, Pages 153-169

  Maull, Elizabeth A ^a,c   Lash, Lawrence H ^b  

^a USAF   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c AIR FORCE RESEARCH LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; GLUTATHIONE; TRICHLOROETHYLENE;

ANIMAL CELL; CANCER INCIDENCE; CANCER RISK; CARCINOGENICITY; CHEMICAL CARCINOGENESIS; DRUG CLASSIFICATION; DRUG MECHANISM; DRUG METABOLISM; HUMAN; HUMAN CELL; LATENT PERIOD; LIVER TUMOR; LUNG TUMOR; NONHUMAN; REVIEW; WATER CONTAMINATION;

ANIMALIA;

EID: 0031891109     PISSN: 10769188     EISSN: None     Source Type: Journal    
DOI: 10.1080/107691898229387     Document Type: Review

References (68)

1. Aersaether, N., Aarsland, A., Kryvi, H., Nilsson, A., Svardal, A., Ueland, P. M., and Berge, R. K. 1989. Changes in peroxisomes and mitochondria in liver of ethionine exposed rats: A biochemical and morphological investigation. Carcinogenesis 10:987-994.
2. Agency for Toxic Substances Disease Registry. 1993. Toxicological Profile for Trichloroethylene (Health Effects Section). U.S. Department of Health and Human Services. Atlanta, GA.
3. Anlberati-Giani, D., Malherbe, P., Köhler, C., Lang, G., Kiefer, V., Lahm, H.-W., and Cesura, A. M. 1995. Cloning and characterization of a soluble kynurenine aminotransferase from rat brain: Identity with kidney cysteine conjugate β-lyase. J. Neurochem. 64:1448-1455.
4. American Conference of Governmental Industrial Hygienists. 1992. Notice of intended change - Trichloroethylene. Appl. Occup. Environ. Hyg. 7:786-791.
5. American Conference of Governmental Industrial Hygienists. 1993. Threshold Limit Values for Chemical Substances and Physical Agents. Cincinnati, OH: ACGIH.
6. Anttila, A., Pukkala, E., Sallmen, M., Hernberg, S., and Hemminki, K. 1995. Cancer incidence among Finnish workers exposed to halogenated hydrocarbons. J. Occup. Med. 37:797-806.
7. Axelson, O., Selden, A., Andersson, K., and Hogstedt, C. 1994. Updated and expanded Swedish cohort study of trichloroethylene and cancer risk. J. Occup. Med. 36:556-562.
8. Bayly, A. C., Roberts, R. A., and Dive, C. 1994. Suppression of liver cell apoptosis in vitro by the nongenotoxic hepatocarcinogen and peroxisome proliferator nafenopin. J. Cell Biol. 125:197-203.
9. Bernauer, U., Birner, G., Dekant, W., and Henschler, D. 1996. Biotransformation of trichloroethene: Dose-dependent excretion of 2,2,2-trichloro-metabolites and mercapturic acids in rats and humans after inhalation. Arch. Toxicol. 70:338-346.
10. Birner, G., Vamvakas, S., Dekant, W., and Henschler, D. 1993. Nephrotoxic and genotoxic N-acetyl-S-dichlorovinyl-L-cysteine is a urinary metabolite after occupational 1,1,2-trichloroethene exposure in humans: Implications for the risk of trichloroethene exposure. Environ. Health Perspect. 99:281-284.
11. u-globulin nephropathy. Annu. Rev. Pharmacol. Toxicol. 30:349-367.
12. Bruckner, J. V., Davis, B. D., and Blancato, J. N. 1989. Metabolism, toxicity, and carcinogenicity of trichloroethylene. CRC Crit. Rev. Toxicol. 20:31-50.
13. Bull, R. J., Templin, M., Larson, J. L., and Stevens, D. K. 1993. The role of dichloro acetate in hepatocarcinogenicity of trichloroethylene. Toxicol. Lett. 68:203-211.
14. Cerutti, P., Ghosh, R., Oya, Y., and Armstad, P. 1994. The role of the cellular antioxidant defense in oxidant carcinogenesis. Environ. Health Perspect. 102:123-130.
15. Cimini, A. M., Sulli, A., Stefanini, S., Serafini, B., Moreno, S., Rossi, L., Giorgi, M., and Ceru, M. P. 1994. Effects of di-(2-ethylhexyl)phthalate on peroxisomes of liver, kidney and brain of lactating rats and their pups. Cell. Mol. Biol. 40:1063-1076.
16. Clewell, H. J., and Andersen, M. E. 1995. Report on the Trichloroethylene Workshop: Williamsburg, Virginia, May 18-19. ICF Kaiser Report for U.S. Air Force, Occupational and Environmental Health Directorate. Ruston, LA.
17. Clewell, H. J., Gentry, P. R., Gearhart, J. M., and Allen, B. C. 1994. Evaluation of Pharmacokinetic Models for Use in Cancer Risk Assessment: Example with Trichloroethylene. ICF Kaiser report prepared for EPA/OHEA and OSHA/DHSP. Ruston, LA.
18. Clewell, H. J., Gentry, P. R., Gearhart, J. M., Allen, B. C., Covington, T. R., and Andersen, M. E. 1995a. Applying Mechanistic Information, Pharmacokinetic Modeling and Margin of Exposure Evaluations in a Novel Risk Assessment for Trichloroethylene and Its Active Carcinogenic Metabolites: Chloral Hydrate, Trichloroacetic Acid, Dichloroacetic Acid, and Dichlorovinylcysteine. ICF Kaiser report prepared for EPA/OHEA and OSHA/DHSP. Ruston, LA.
19. Clewell, H. J., Gentry, P. R., Gearhart, J. M., Allen, B. C., and Andersen, M. E. 1995b. Considering pharmacokinetic and mechanistic information in cancer risk assessments for environmental contaminants: Examples with vinyl chloride and trichloroethylene. Chemosphere 31:2561-2578.
20. Commandeur, J. N. M., and Vermeulen, N. P. E. 1990. Identification of N-acetyl(2,2-dichlorovinyl)-and N-acetyl(1,2-dichlorovinyl)-L-cysteine as two regioisomeric mercapturic acids of trichloroethylene in rats. Toxicol. Appl. Pharmacol. 110:303-314.
21. Dekant, W., Metzler, M., and Henschler, D. 1986a. Identification of S-(1,2-dichlorovinyl)-N-acetyl-cysteme as a urinary metabolite of trichloroethylene: A possible explanation for its nephrocarcinogenicity in male rats. Biochem. Pharmacol. 35:2455-2458.
22. Dekant, W., Schultz, A., Metzler, M., and Henschler, D. 1986b. Absorption, elimination and metabolism of trichloroethylene: A quantitative comparison between rats and mice. Xenobiotica 16:143-152.
23. Dohn, D. R., and Anders, M. W. 1982. Assay of cysteine conjugate β-lyase activity with S-(2-benzothiazolyl) cysteine as substrate. Anal. Biochem. 120:379-386.
24. Elcombe, C. R. 1985. Species differences in carcinogenicity and peroxisome proliferation due to trichloroethylene: A biochemical human hazard assessment. Arch. Toxicol. 8(suppl.):6-17.
25. Gist, G. L., and Burg, J. R. 1995. Trichloroethylene - A review of the literature from a health effects perspective. Toxicol. Ind. Health 11:253-307.
26. Green, T., and Prout, M. S. 1985. Species differences in response to trichloroethylene. II. Biotransformation in rats and mice. Toxicol. Appl. Pharmacol. 79:401-411.
27. International Agency for Research on Cancer. 1979. Some halogenated hydrocarbons. Monogr. Eval. Carcinogen. Risk Chem. Hum., 20, Lyons: World Health Organization.
28. International Agency for Research on Cancer. 1995. Dry cleaning, some chlorinated solvents and other industrial chemicals. IARC Monogr. Eval. Carcinogen. Risks Hum. 63.
29. Larsen, G. L., and Stevens, J. L. 1986. Cysteine conjugate β-lyase in the gastrointestinal bacterium Eubacterium limosum. Mol. Pharmacol. 29:97-103.
30. Larson, J. L., and Bull, R. J. 1992a. Species differences in the metabolism of trichloroethylene to the carcinogenic metabolites trichloroacetate and dichloroacetate. Toxicol. Appl. Pharmacol. 115:278-285.
31. Larson, J. L., and Bull, R. J. 1992b. Metabolism and lipoperoxidative activity of trichloroacetate and dichloroacetate in rats and mice. Toxicol. Appl. Pharmacol. 115:268-277.
32. Lash, L. H., Elfarra, A. A., and Anders, M. W. 1986. Renal cysteine conjugate β-lyase: Bioactivation of nephrotoxic cysteine S-conjugates in mitochondrial outer membrane. J. Biol. Chem. 261:5930-5935.
33. Lash, L. H., Jones, D. P., and Anders, M. W. 1988. Glutathione homeostasis and glutathione S-conjugate toxicity in kidney. Rev. Biochem. Toxicol. 9:29-67.
34. Lash, L. H., Nelson, R. M., Van Dyke, R. A., and Anders, M. W. 1990. Purification and characterization of human kidney cysteine conjugate β-lyase activity. Drug Metab. Dispos. 18:50-54.
35. Lash, L. H., Xu, Y., Elfarra, A. A., Duescher, R. J., and Parker, J. C. 1995. Glutathione-dependent metabolism of trichloroethylene in isolated liver and kidney cells of rats and its role in mitochondrial and cellular toxicity. Drug. Metab. Dispos. 23:846-853.
36. Lehman-McKeeman, L. D. 1993. Male rat-specific light hydrocarbon nephropathy. In Toxicology of the kidney, 2nd ed., eds. J. B. Hook and R. S. Goldstein, pp. 477-494. New York: Raven Press.
37. Lehman-McKeeman, L. D., Rivera-Torres, M. I., and Caudill, D. 1990. Lysosomal degradation of α2u-globulin and α2u-globulin-xenobiotic conjugates. Toxicol. Appl. Pharmacol. 103:539-548.
38. Malherbe, P., Alberati-Giani, D., Köhler, C., and Cesura, A. M. 1995. Identification of a mitochondrial form of kynurenine aminotransferase/glutamine transaminase K from rat brain. FEBS Lett. 367:141-144.
39. Maull, E. A., Cogliano, V. J., Scott, C. S., Barton, H. A., Fisher, J. W., Greenberg, M., Rhomberg, L., and Sorgen, S. P. 1997. Trichloroethylene Health Risk Assessment: A New and Improved Process, Drug Chem. Toxicol., 20:426-442.
40. Melnick, R. 1992. An alternative hypothesis on the role of chemically induced protein droplet (α2u-globin) nephropathy in renal carcinogenesis. Regul. Toxicol. Pharmacol. 16:111-125.
41. Miller, R. E., and Guengerich, F. P. 1982. Oxidation of trichloroethylene by liver microsomal cytochrome P-450: Evidence for chlorine migration in a transition state not involving trichloroethylene oxide. Biochemistry 21:1090-1097.
42. Miller, R. E., and Guengerich, F. P. 1983. Metabolism of trichloroethylene in isolated hepatocytes, microsomes, and reconstituted systems containing cytochrome P-450. Cancer Res. 43:1145-1152.
43. National Research Council. 1995. Biologic markers in urinary toxicology, Chapter 6. Washington, DC: National Academy Press.
44. Nemali, M. R., Usuda, N., Reddy, M. K., Oyasu, K., Hashimoto, T., Osumi, T., Rao, M. S., and Reddy, J. K. 1988. Comparison of constitutive and inducible levels of expression of peroxisomal beta-oxidation and catalase genes in liver and extrahepatic tissues of rat. Cancer Res. 48:5316-5324.
45. Odum, J., Green, T., Foster, J. R., and Hext, P. M. 1988. The role of trichloroacetic acid and peroxisome proliferation in the differences in carcinogenicity of perchloroethylene in the mouse and rat. Toxicol. Appl. Pharmacol. 92:103-112.
46. Odum, J., Foster, J. R., and Green, T. 1992. A mechanism for the development of Clara cell lesions in the mouse lung after exposure to trichloroethylene. Chem. Biol. Interact. 83:135-153.
47. Ponchaut, S., Draye, J. P., Veitch, K., and van Hoof, F. 1991. Influence of chronic administration of valproate on ultrastructure and enzyme content of peroxisomes in rat liver and kidney. Biochem. Pharmacol. 41:1419-1428.
48. Rao, M. S., and Reddy, J. K. 1991. An overview of peroxisome proliferator-induced hepatocarcinogenesis. Environ. Health Perspect. 93:205-209.
49. Reitz, R. H., Gargas, M. L., and Hays, S. 1995. Development of a Physiologically-Based Pharmacokinetic Model for Trichloroethylene and Its Major Metabolites. ChemRisk report to the Medical University of South Carolina, prepared for the Department of Energy. Midland, MI.
50. Richmond, R. E., DeAngelo, A. B., Potter, C. L., and Daniel, F. B. 1991. The role of hyperplastic nodules in dichloroacetic acid-induced hepatocarcinogenesis in B6C3F1 male mice. Carcinogenesis 12:1383-1387.
51. Richmond, R. E., Carter, J. H., Carter, H. W., Daniel, F. B., and DeAngelo, A. B. 1995. Immunohistochemical analysis of dichloroacetic acid (DCA)-induced hepatocarcinogenesis in male Fischer (F433) rats. Cancer Lett. 92:67-76.
52. Rijhsinghani, K. S., Abrahams, C., Swerdlow, M. A., Rao, K. V., and Ghose, T. 1986. Induction of neoplastic lesions in the livers of C57B1 X C3HF1 mice by chloral hydrate. Cancer Detect. Prev. 9:279-288.
53. Schultze-Hermann, R., Bursch, W., Kraupp-Grasl, B., Oberhammer, F., Wagner, A., and Jirtle, R. 1993. Cell proliferation and apoptosis in normal liver and preneoplastic foci. Environ. Health Perspect. 101:87-90.
54. Snyder, R. D., Pullman, J., Carter, J. H., Carter, H. W., and DeAngelo, A. B. 1995. In vivo administration of dichloroacetic acid suppresses spontaneous apoptosis in murine hepatocytes. Cancer Res. 55:3702-3705.
55. Spirtas, R., Stewart, P., and Lee, S. 1991. Retrospective cohort mortality study of workers at an aircraft maintenance facility. II. Exposures and the assessment. Br. J. Ind. Med. 48:531-537.
56. Steinberg, A. D., and DeSesso, J. M. 1993. Have animal data been used inappropriately to estimate risks to humans from environmental trichloroethylene? Regul. Toxicol. Pharmacol. 18:137-153.
57. Stevens, J. L. 1985a. Cysteine conjugate β-lyase in rat kidney cortex: Subcellular localization and relationship to the hepatic enzymes. Biochem. Biophys. Res. Commun. 129:499-504.
58. Stevens, J. L. 1985b. Isolation and characterization of a rat liver enzyme with both cysteine conjugate β-lyase activity and kynureninase activity. J. Biol. Chem. 260:7945-7950.
59. Stevens, J. L., and Jakoby, W. B. 1983. Cysteine conjugate β-layse. Mol. Pharmacol. 23:761-765.
60. Styles, J. A., Wyatt, I., and Coutts, C. 1991. Trichloroacetic acid: Studies on uptake and effects on hepatic DNA and liver growth in mouse. Carcinogenesis 12:1715-1719.
61. Sundseth, S. S., and Waxman, D. J. 1992. Sex-dependent expression and clofibrate inducibility of cytochrome P450 4A fatty acid omega-hydroxylases. Male specificity of liver and kidney CYP4A2 mRNA and tissue-specific regulation by growth hormone and testosterone. J. Biol. Chem. 267:3915-3921.
62. 2u-Globulin nephropathy: Review of the cellular and molecular mechanisms involved and their implications for human risk assessment. Environ. Health Perspect. Suppl. 6:39-44.
63. Templin, M. V., Stevens, D. K., Stenner, R. D., Bonate, P. L., Tuman, D., and Bull, R. J. 1995. Factors affecting species differences in the kinetics of metabolites of trichloroethylene. J. Toxicol. Environ. Health 44:435-447.
64. Tomisawa, H., Suzuki, S., Ichihara, S., Fukazawa, H., and Tateishi, M. 1984. Purification and characterization of C-S lyase from Fusobacterium varium: A C-S cleavage enzyme of cysteine conjugates and some S-containing amino acids. J. Biol. Chem. 259:2588-2593.
65. Tomisawa, H., Ichihara, S., Fukazawa, H., Ichimoto, N., Tateishi, M., and Yamamoto, I. 1986. Purification and characterization of human hepatic cysteine conjugate β=lyase. Biochem. J. 259:2588-2593.
66. U.S. Environmental Protection Agency. 1987. Environmental Protection Agency (EPA) Update to the Health Assessment Document for Trichloroethylene: Updated. Carcinogenicity Assessment for Trichloroethylene. External Review Draft. EPA/600/8-82/006FA. Washington, DC: U.S. EPA.
67. U.S. Environmental Protection Agency. 1996. Proposed guidelines for carcinogen risk assessment: notice. Fed. Reg. 61:17960-18011.
68. U.S. Environmental Protection Agency. 1997. Glossary of risk assessmentrelated terms. From the U.S. EPA Internet Homepage, http://www.epa.gov/ngispgm3/iris/glossary.html/.